OOIR: Observatory of International Research

Papers

(The TQCC of Climacteric is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Peer reviewers for Climacteric in 2024	206
Safety and acceptability of intravaginal rings releasing estradiol and progesterone	106
Low thrombin generation in postmenopausal women using estetrol	92
Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health	80
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted	65
Redefining menopausal care: a randomized trial of group CBT for vasomotor symptoms in Korean women	55
Effects of jazz dance and concurrent training on physical variables in postmenopausal women	41
The International Menopause Society celebrates another milestone	40
Variations in the prevalence of premature and early menopause in low and middle-income regions: a cross-sectional study	38
Influence of estradiol deficiency on the mineralocorticoid receptor response in postmenopausal women: a cross-sectional study	33
Awareness of menopause and menopause hormone therapy in India: perspectives of healthcare providers and consumers	32
Peer reviewers for Climacteric in 2022	32
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia	30
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women	29
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy	27
Multidimensional menopausal symptom burden in Singapore – MARIE work package 2a population analysis	26
Women’s experience and management of cognition during menopause transition: a qualitative study	26
The musculoskeletal syndrome of menopause	24
Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG)	24
Quo vadis?	23
Good night and good luck	22
Hormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis	22
Association of serum uric acid with handgrip strength and dynapenia in postmenopausal women	20
Comparison of predicted aerobic capacity to measured aerobic capacity in menopausal women: an analysis of three methods	20
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA	18

‘Menopausando’: a digital health education platform for women in the transition to menopause and postmenopause	18
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China	17
The impact of ovarian aging on muscle strength and life quality in various reproductive aging stages	17
Treatment, perceptions and burden of vasomotor symptoms among midlife women in Japan	17
Menopausal symptoms among perimenopausal women in rural Turkey: a cross-sectional study	17
VDRgeneApaI polymorphism and risk of postmenopausal osteoporosis: a meta-analysis from 22 studies	16
What is the evidence for the effect of physical exercise on bone health in menopausal women? An umbrella systematic review	16
Not just sex: other roles for testosterone in women	16
Thank you	15
The LADY study: epidemiological characteristics of prevalent and new genitourinary syndrome of menopause cases in Greece	15
NK3 receptor antagonist alters the centrally controlled perception of menopausal flushing – a pilot study	15
Younger midlife females with bilateral salpingo-oophorectomy: respiratory disturbances during sleep	14
Correction	14
Factors influencing seogeulpeum among middle-aged Korean women	14
Adjuvant treatment with tamoxifen for estrogen receptor-positive breast cancer and gynecological risks in premenopausal and perimenopausal women – a systematic review	13
Oxidative balance score and periodontitis in postmenopausal women: a nationwide study	13
Practices and challenges in the management of the menopause in the Asia-Pacific Menopause Federation	13
Understanding experiences and views of the menopause in Zimbabwe and South Africa: a qualitative study	13
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index	13
Follicle stimulating hormone, luteinizing hormone and adiposity trajectories in postmenopausal women	13
Progesterone and not estrogens or androgens causes breast cancer	13
Reproductive milestones across the lifespan and cardiovascular disease risk in women	13
Management of obesity in menopause	12
Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism: a systematic review	12
The next chapter	12
Impact of overweight and obesity in postmenopausal women	12
From tissue to outcome – how perioperative vaginal estrogen transforms prolapse surgery results: a systematic review and meta-analysis of clinical evidence and outcomes	12
POESIT recommendations on management of body-identical hormones in menopausal symptoms	12
Is the patients’ fear of cancer the main barrier to prescribing menopausal hormone therapy?	12
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion	11
Menopausal age and cardiovascular disease risk in American women: evidence from the National Health and Nutrition Examination Survey	11
Do menopausal symptoms signal early biological aging? Mitochondrial, endocrine and clinical insights	11
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss	11
COVID-19-related premature ovarian insufficiency: case report and literature review	11
Age and diagnostic assessment of natural menopause in low-weight women	10
Premature ovarian insufficiency: addressing the most controversial issues	10
Management of menopause: a survey of physicians from the Middle East and Africa	10
The yin and yang of GSM and low sexual desire	10
Menarche, menopause and reproductive span in relation to frailty trajectories in Chinese women	10
Statement of Retraction: Rapid and random-start endometrial preparation before outpatient hysteroscopic polypectomy in patients of perimenopausal age	10
Neuroprotective effect of hormone replacement therapy: a review of the literature	10
Chai-shen powder treated perimenopausal syndrome through the PI3K–Akt/cAMP signaling pathway: integrated clinical analysis, network pharmacology, microRNA and animal experiment	10
Therapeutic effects of curculigoside on cyclophosphamide-induced premature ovarian failure in mice	9
Prevalence, impact and management of postmenopausal symptoms among postmenopausal women in Rwanda	9
Perimenopausal migraine: a narrative review	9
Response to commentary on “Intermittent walking training improves thyroid function and cardiometabolic risk factors in postmenopausal women”	9
Menopause hormone treatment after cancer	9
Photobiomodulation therapy in the treatment of genitourinary syndrome in postmenopausal women – a placebo-controlled double-blind clinical trial	9
The association between day-to-day impact of vaginal aging and female sexual function	9
Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women’s midlife health	9

Effect of hormone therapy on personality traits: preliminary evidence in older men and women	8
Is it possible that menopause is associated with telomere length? Findings of an integrative review	8
Sleep disorders and menopausal symptoms: a Latin American perspective on postmenopausal health	8
The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition	8
Hot flashes: a potential marker of deterioration of health-related quality of life	8
Psychosomatic and medical experiences of menopause in Chinese women: a social media study	8
In search of a well-balanced narrative of the menopause momentum	8
Corneal thickness, contrast sensitivity and binocular vision in menopausal and non-menopausal women	8
Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study	8
Rebalancing the narrative on MHT – the menopause momentum continues following FDA ‘unboxing’!	8
IMS World Congress on Menopause	7
Endometriosis beyond menopause: a call for greater clinical awareness	7
Peer reviewers for Climacteric in 2023	7
Body composition and self-perception of age and health in resistance-trained postmenopausal women	7
Pulmonary embolism in menopausal hormone therapy: a population-based register study	7
Does the environment affect menopause? A review of the effects of endocrine disrupting chemicals on menopause	7
REDLINC: two decades of collaborative insights into menopause and women’s health in Latin America	7
Testosterone for women: certainties and uncertainties	7
Sexual dysfunction and quality of life in postmenopausal type 2 diabetes mellitus: clinical and laboratory factors	7
Endocrine consequences of breast cancer therapy and survivorship	7
The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis	7